Refine by
Wound Treatment Devices Articles & Analysis
14 news found
The acquisition enables Healiva® to establish one of the world’s broadest portfolios of affordable, personalized, end-to-end wound care consisting of enzyme technology, autologous & allogenic cell therapies, and medical devices. ...
Microbion Corporation of Bozeman, MT, today announced that it has received non-dilutive funding through its strategic partnership with CUBRC, Inc., a Buffalo-based, independent not-for-profit research company, of up to $2.1 million from the US Navy through the Medical Technology Enterprise Consortium (MTEC) partnership. The funding project is titled “Pravibismane Suspension as a Topical, ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
EP 3461438 titled "Combined Intracorporeal and Extracorporeal Shock Wave Treatment System," with the United Kingdom, France, Germany, and Netherland as designated countries. ...
Urgent care providers are responsible for providing treatment that promotes healing and helps prevent wound infection. New wound closure options like the microMend bandage may help. ...
microMend is an exciting new technology that reduces patient wait time while also providing the highest level of care. microMend is a wound closure device that shaped like a butterfly bandage and applied easily. ...
Dermatologists may perform a number of in-office procedures that result in wounds, including biopsies and mole excisions. Traditional options for repairing these wounds include sutures, staples, adhesive strips, and other suture types. However, traditional wound care methods have several drawbacks, including cost, time, and patient limitations. New wound closure options, such as the microMend ...
microMend is a butterfly shaped bandage which securely closes wounds using an array of stainless steel microstaples that securely fasten to the skin. It is as effective as staples or sutures for wound closure without the cost and clinical expertise required for traditional skin closure methods. ...
microMend PRO is a revolutionary new wound closure device that combines the application ease of a bandage with the wound sealing prowess of sutures. This innovative technology delivers superior results and increased patient satisfaction and reduces the cost of dermatology wound care. microMend PRO is a butterfly-shaped ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for focused, shockwave systems in the non-medical field today presented results from a clinical case series that demonstrated improved wound healing when treated with its FDA-cleared, ...
SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. The new brand reflects the evolution of SANUWAVE’s solutions addressing the entire wound care pathway through its portfolio of noninvasive and ...
August 3, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable Closer Vascular Sealing System (VSS) to achieve rapid hemostasis of femoral artery catheterizations. The vascular closure device consists of an insertion sheath, dilator and an implant contained in a delivery system. It uses a patch placed against the artery wall ...
BioLargo, Inc. (OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to support the FDA approval and commercial launch of Clyra's advanced wound care products. Clyra Medical Technologies holds the exclusive license to commercialize ...
Rhodes will work closely with BioLargo and its recently formed medical subsidiary to commercialize its technology in the wound management and medical device markets. "I believe that the BioLargo technology presents a unique and cost-effective solution for a number of big problems facing the industry," stated Rhodes. ...